Ultrasound brain stimulation for freezing of gait in Parkinson's
Part of Brain & nervous system clinical trials.
This trial tests a noninvasive ultrasound treatment targeting a brain area called the pedunculopontine nucleus to help reduce freezing of gait (a sudden inability to walk) in Parkinson's disease. If you have Parkinson's and experience freezing, you may be eligible to try this new approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old
- You have Parkinson's disease with freezing of gait
- Your Parkinson's medication dose has been stable for at least 4 weeks
- You have not had a stroke or seizure
- You do not have dementia and scored 22 or higher on a recent memory test (the Montreal Cognitive Assessment)
- You have no metal implants in your head, no pacemaker or defibrillator, and no previous brain surgery for Parkinson's
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a brain-computer interface device to help people with Parkinson's disease who experience freezing of gait. The goal is to see if the device can reduce freezing episodes when medication isn't enough.
This study tests a new type of brain stimulation that may help people with Parkinson's disease who experience freezing of gait (when your feet feel stuck to the floor). It uses a non-invasive technique called transcranial magnetic stimulation (TMS) that sends magnetic pulses through the scalp to activate brain cells, without surgery.
This study tests a new type of deep brain stimulation (DBS) targeting a specific brain area to help people with Parkinson's disease who have severe freezing of gait that doesn't improve with medication. It aims to see if this treatment can reduce freezing episodes and improve walking.
This study looks at how a special brain pacemaker (called the Medtronic Percept device) affects walking problems like freezing of gait in people with Parkinson's. It aims to help understand and improve treatment.
This trial tests an adaptive deep brain stimulation (DBS) system designed to improve freezing of gait in Parkinson’s disease. It is for people who still have trouble walking despite medications and are already planning to have DBS surgery.
This trial tests whether atomoxetine, a drug that boosts a brain chemical called noradrenaline, can help reduce freezing of gait—a feeling of your feet being stuck to the ground—in people with Parkinson's disease. You would continue your usual Parkinson's medications during the study and undergo walking tests and brain scans to see if the drug helps.
Hear when a new Freezing of Gait Symptoms in Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.